Preferred Pharmaceuticals, Inc. is recalling 276 bottles of Alprazolam Tablets (USP 1mg), which is the generic version of Xanax. This recall was initiated due to manufacturing deviations (CGMP deviations) reported by the manufacturer. The affected products were distributed nationwide in the United States in 30, 60, and 90-count bottles. No incidents or injuries have been reported in connection with this recall.
Manufacturing deviations can mean a medication does not meet strict quality or safety standards, which may result in the drug being less effective or having unintended quality issues. While no injuries have been reported, consumers should ensure they are using medication that meets all safety and manufacturing requirements.
You have 2 options:
Manufactured by Par Pharmaceutical and repacked/distributed by Preferred Pharmaceuticals, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.